NK Cells Can Preferentially Target Prostate Cancer Stem-like Cells via the TRAIL/DR5 Signaling Pathway

Background: The occurrence of androgen-dependent prostate cancer mainly depends on prostate cancer stem cells. To reduce the risk of androgen-dependent prostate cancer, the direct elimination of prostate cancer stem cells is important, but an elimination strategy has not yet been established. A prev...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Taiga Seki, Yui Shimizu, Kyota Ishii, Yuzuki Takahama, Kazunori Kato, Tomohiro Yano
Formato: article
Lenguaje:EN
Publicado: MDPI AG 2021
Materias:
Acceso en línea:https://doaj.org/article/997fb96bdb004b629302cfe1b5a2b71e
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:997fb96bdb004b629302cfe1b5a2b71e
record_format dspace
spelling oai:doaj.org-article:997fb96bdb004b629302cfe1b5a2b71e2021-11-25T16:53:58ZNK Cells Can Preferentially Target Prostate Cancer Stem-like Cells via the TRAIL/DR5 Signaling Pathway10.3390/biom111117022218-273Xhttps://doaj.org/article/997fb96bdb004b629302cfe1b5a2b71e2021-11-01T00:00:00Zhttps://www.mdpi.com/2218-273X/11/11/1702https://doaj.org/toc/2218-273XBackground: The occurrence of androgen-dependent prostate cancer mainly depends on prostate cancer stem cells. To reduce the risk of androgen-dependent prostate cancer, the direct elimination of prostate cancer stem cells is important, but an elimination strategy has not yet been established. A previous study showed that natural killer (NK) cells can preferentially target cancer stem cells in several solid tumors except prostate cancer. In this context, this study was undertaken to investigate if NK cells can selectively attack androgen-dependent prostate cancer stem cells. Methods: Prostate cancer stem-like cells were separated from an androgen-dependent prostate cancer cell line (LNCaP) using a three-dimensional culture system. LNCaP stem-like cells or LNCaP cells were co-cultured with human NK cells (KHYG-1) for 24–72 h, and cell viability was determined using the WST-8 method. The expression of each protein in the cell membrane was evaluated through FACS analysis, and mRNA levels were determined using real-time PCR. Results: KHYG-1 cells had more potent cytotoxicity against LNCaP stem-like cells than LNCaP cells, and the potency of the cytotoxicity was strongly related to the TRAIL/DR5 cell death pathway. Conclusion: NK cells can preferentially target prostate cancer stem-like cells via the TRAIL/DR5 pathway.Taiga SekiYui ShimizuKyota IshiiYuzuki TakahamaKazunori KatoTomohiro YanoMDPI AGarticleandrogen-dependent prostate cancerstem cellsNK cellscytotoxicityTRAIL/DR5 signal pathwayMicrobiologyQR1-502ENBiomolecules, Vol 11, Iss 1702, p 1702 (2021)
institution DOAJ
collection DOAJ
language EN
topic androgen-dependent prostate cancer
stem cells
NK cells
cytotoxicity
TRAIL/DR5 signal pathway
Microbiology
QR1-502
spellingShingle androgen-dependent prostate cancer
stem cells
NK cells
cytotoxicity
TRAIL/DR5 signal pathway
Microbiology
QR1-502
Taiga Seki
Yui Shimizu
Kyota Ishii
Yuzuki Takahama
Kazunori Kato
Tomohiro Yano
NK Cells Can Preferentially Target Prostate Cancer Stem-like Cells via the TRAIL/DR5 Signaling Pathway
description Background: The occurrence of androgen-dependent prostate cancer mainly depends on prostate cancer stem cells. To reduce the risk of androgen-dependent prostate cancer, the direct elimination of prostate cancer stem cells is important, but an elimination strategy has not yet been established. A previous study showed that natural killer (NK) cells can preferentially target cancer stem cells in several solid tumors except prostate cancer. In this context, this study was undertaken to investigate if NK cells can selectively attack androgen-dependent prostate cancer stem cells. Methods: Prostate cancer stem-like cells were separated from an androgen-dependent prostate cancer cell line (LNCaP) using a three-dimensional culture system. LNCaP stem-like cells or LNCaP cells were co-cultured with human NK cells (KHYG-1) for 24–72 h, and cell viability was determined using the WST-8 method. The expression of each protein in the cell membrane was evaluated through FACS analysis, and mRNA levels were determined using real-time PCR. Results: KHYG-1 cells had more potent cytotoxicity against LNCaP stem-like cells than LNCaP cells, and the potency of the cytotoxicity was strongly related to the TRAIL/DR5 cell death pathway. Conclusion: NK cells can preferentially target prostate cancer stem-like cells via the TRAIL/DR5 pathway.
format article
author Taiga Seki
Yui Shimizu
Kyota Ishii
Yuzuki Takahama
Kazunori Kato
Tomohiro Yano
author_facet Taiga Seki
Yui Shimizu
Kyota Ishii
Yuzuki Takahama
Kazunori Kato
Tomohiro Yano
author_sort Taiga Seki
title NK Cells Can Preferentially Target Prostate Cancer Stem-like Cells via the TRAIL/DR5 Signaling Pathway
title_short NK Cells Can Preferentially Target Prostate Cancer Stem-like Cells via the TRAIL/DR5 Signaling Pathway
title_full NK Cells Can Preferentially Target Prostate Cancer Stem-like Cells via the TRAIL/DR5 Signaling Pathway
title_fullStr NK Cells Can Preferentially Target Prostate Cancer Stem-like Cells via the TRAIL/DR5 Signaling Pathway
title_full_unstemmed NK Cells Can Preferentially Target Prostate Cancer Stem-like Cells via the TRAIL/DR5 Signaling Pathway
title_sort nk cells can preferentially target prostate cancer stem-like cells via the trail/dr5 signaling pathway
publisher MDPI AG
publishDate 2021
url https://doaj.org/article/997fb96bdb004b629302cfe1b5a2b71e
work_keys_str_mv AT taigaseki nkcellscanpreferentiallytargetprostatecancerstemlikecellsviathetraildr5signalingpathway
AT yuishimizu nkcellscanpreferentiallytargetprostatecancerstemlikecellsviathetraildr5signalingpathway
AT kyotaishii nkcellscanpreferentiallytargetprostatecancerstemlikecellsviathetraildr5signalingpathway
AT yuzukitakahama nkcellscanpreferentiallytargetprostatecancerstemlikecellsviathetraildr5signalingpathway
AT kazunorikato nkcellscanpreferentiallytargetprostatecancerstemlikecellsviathetraildr5signalingpathway
AT tomohiroyano nkcellscanpreferentiallytargetprostatecancerstemlikecellsviathetraildr5signalingpathway
_version_ 1718412853279457280